SCHEMBL732495

SCHEMBL732495

CC(=O)C(C)C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16248435 1.00
SCHEMBL19275819 1.00
SCHEMBL11064739 0.78 TSHR (0.41)
SCHEMBL185750 0.75
SCHEMBL9494396 0.75
SCHEMBL9497647 0.75
SCHEMBL8962163 0.73
Acetone SCHEMBL28634611 0.73
SCHEMBL8182250 0.73
SCHEMBL13858443 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7141693-B2 Process for producing β-oxonitrile compound or alkali metal salt thereof UBE INDUSTRIES, LTD. (JP) 2006-11-28 US claimed
US-12492187-B2 Factor XI activation inhibitors MERCK SHARP & DOHME LLC (US) 2025-12-09 US disclosed
CN-115403584-B 2-thio-2, 3-dihydropyrimidine-4-one derivatives, pharmaceutical compositions, preparation methods and applications thereof 长春金赛药业有限责任公司 2024-04-02 CN disclosed
US-20230147170-A1 FACTOR XI ACTIVATION INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-05-11 US disclosed
US-20230147170-A1 FACTOR XI ACTIVATION INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-05-11 US disclosed
EP-4125892-A1 FACTOR XI ACTIVATION INHIBITORS Merck Sharp & Dohme LLC (US) 2023-02-08 EP disclosed
CN-115403584-A 2-thio-2, 3-dihydropyrimidine-4-one derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2022-11-29 CN disclosed
WO-2021202254-A1 FACTOR XI ACTIVATION INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-10-07 WO disclosed
US-10889589-B2 Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain ARRAY BIOPHARMA INC. (US) 2021-01-12 US disclosed
EP-3650514-A1 ULTRAVIOLET CURABLE SILICONE ADHESIVE COMPOSITION AND SILICONE ADHESIVE FILM Shin-Etsu Chemical Co., Ltd. (JP) 2020-05-13 EP disclosed
CN-1562985-A Preparation method of 5-substituted-3-aminoisoxazole compound SHANGHAI INST OPTICS & FINE ME (CN) 2005-01-12 CN disclosed
US-20040171863-A1 Process for poducing beta-oxonitrile compound or alkali metal salt thereof UBE INDUSTRIES, LTD. (JP) 2004-09-02 US disclosed
EP-0296550-B1 Phosphonium salts and processes for production of and uses for the same KURARAY CO (JP) 1993-12-29 EP disclosed
US-5100854-A Telomerization catalysts KURARAY CO., LTD. (JP) 1992-03-31 US disclosed
US-4992609-A Telomerization catalysts KURARAY CO., LTD. (JP) 1991-02-12 US disclosed
US-4927960-A TELOMERIZATION CATALYST KURARAY COMPANY, LTD. (JP) 1990-05-22 US disclosed
EP-0296550-A2 Phosphonium salts and processes for production of and uses for the same KURARAY CO., LTD. (JP) 1988-12-28 EP disclosed
US-4363816-A TREATMENT OF GASTROINTESTINAL DISORDERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1982-12-14 US disclosed
US-4234594-A Pyrazolyl amino imidazolines as antihypertensive agents ABBOTT LABORATORIES (US) 1980-11-18 US disclosed
US-4226773-A Pyrazolyl amino imidazolines as diuretic agents ABBOTT LABORATORIES (US) 1980-10-07 US disclosed